344 related articles for article (PubMed ID: 29305692)
41. Recognition of Mycoplasma hyorhinis by CD99-Fc molecule.
Gazit R; Rechnitzer H; Achdout H; Katzenell A; Katz G; Markel G; Arnon TI; Gonen-Gross T; Mizrahi S; Gruda R; Rottem S; Mandelboim O
Eur J Immunol; 2004 Jul; 34(7):2032-40. PubMed ID: 15214051
[TBL] [Abstract][Full Text] [Related]
42. CD99 is a key mediator of the transendothelial migration of neutrophils.
Lou O; Alcaide P; Luscinskas FW; Muller WA
J Immunol; 2007 Jan; 178(2):1136-43. PubMed ID: 17202377
[TBL] [Abstract][Full Text] [Related]
43. CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activity.
Zucchini C; Manara MC; Pinca RS; De Sanctis P; Guerzoni C; Sciandra M; Lollini PL; Cenacchi G; Picci P; Valvassori L; Scotlandi K
Oncogene; 2014 Apr; 33(15):1912-21. PubMed ID: 23644663
[TBL] [Abstract][Full Text] [Related]
44. Engagement of CD99 Reduces AP-1 Activity by Inducing BATF in the Human Multiple Myeloma Cell Line RPMI8226.
Gil M; Pak HK; Park SJ; Lee AN; Park YS; Lee H; Lee H; Kim KE; Lee KJ; Yoon DH; Chung YS; Park CS
Immune Netw; 2015 Oct; 15(5):260-7. PubMed ID: 26557810
[TBL] [Abstract][Full Text] [Related]
45. CD99 engagement on human peripheral blood T cells results in TCR/CD3-dependent cellular activation and allows for Th1-restricted cytokine production.
Waclavicek M; Majdic O; Stulnig T; Berger M; Sunder-Plassmann R; Zlabinger GJ; Baumruker T; Stöckl J; Ebner C; Knapp W; Pickl WF
J Immunol; 1998 Nov; 161(9):4671-8. PubMed ID: 9794396
[TBL] [Abstract][Full Text] [Related]
46. Immunohistochemical analysis of NKX2.2, ETV4, and BCOR in a large series of genetically confirmed Ewing sarcoma family of tumors.
Machado I; Yoshida A; López-Guerrero JA; Nieto MG; Navarro S; Picci P; Llombart-Bosch A
Pathol Res Pract; 2017 Sep; 213(9):1048-1053. PubMed ID: 28864350
[TBL] [Abstract][Full Text] [Related]
47. Immunoreactivity of CD99 in invasive malignant melanoma.
Wilkerson AE; Glasgow MA; Hiatt KM
J Cutan Pathol; 2006 Oct; 33(10):663-6. PubMed ID: 17026517
[TBL] [Abstract][Full Text] [Related]
48. Identification of cyclophilin A as a CD99-binding protein by yeast two-hybrid screening.
Kim HJ; Chong KH; Kang SW; Lee JR; Kim JY; Hahn MJ; Kim TJ
Immunol Lett; 2004 Sep; 95(2):155-9. PubMed ID: 15388255
[TBL] [Abstract][Full Text] [Related]
49. The murine CD99-related molecule CD99-like 2 (CD99L2) is an adhesion molecule involved in the inflammatory response.
Schenkel AR; Dufour EM; Chew TW; Sorg E; Muller WA
Cell Commun Adhes; 2007; 14(5):227-37. PubMed ID: 18163232
[TBL] [Abstract][Full Text] [Related]
50. CD99 regulates CXCL12-induced chemotaxis of human plasma cells.
Gil M; Pak HK; Lee AN; Park SJ; Lee Y; Roh J; Lee H; Chung YS; Park CS
Immunol Lett; 2015 Dec; 168(2):329-36. PubMed ID: 26522646
[TBL] [Abstract][Full Text] [Related]
51. CD99 type II is a determining factor for the differentiation of primitive neuroectodermal cells.
Lee EJ; Lee HG; Park SH; Choi EY; Park SH
Exp Mol Med; 2003 Oct; 35(5):438-47. PubMed ID: 14646598
[TBL] [Abstract][Full Text] [Related]
52. Endothelial CD99 signals through soluble adenylyl cyclase and PKA to regulate leukocyte transendothelial migration.
Watson RL; Buck J; Levin LR; Winger RC; Wang J; Arase H; Muller WA
J Exp Med; 2015 Jun; 212(7):1021-41. PubMed ID: 26101266
[TBL] [Abstract][Full Text] [Related]
53. Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor.
Folpe AL; Hill CE; Parham DM; O'Shea PA; Weiss SW
Am J Surg Pathol; 2000 Dec; 24(12):1657-62. PubMed ID: 11117787
[TBL] [Abstract][Full Text] [Related]
54. Ectodomain shedding of CD99 within highly conserved regions is mediated by the metalloprotease meprin β and promotes transendothelial cell migration.
Bedau T; Peters F; Prox J; Arnold P; Schmidt F; Finkernagel M; Köllmann S; Wichert R; Otte A; Ohler A; Stirnberg M; Lucius R; Koudelka T; Tholey A; Biasin V; Pietrzik CU; Kwapiszewska G; Becker-Pauly C
FASEB J; 2017 Mar; 31(3):1226-1237. PubMed ID: 28003343
[TBL] [Abstract][Full Text] [Related]
55. CD99 isoforms expression dictates T cell functional outcomes.
Alberti I; Bernard G; Rouquette-Jazdanian AK; Pelassy C; Pourtein M; Aussel C; Bernard A
FASEB J; 2002 Dec; 16(14):1946-8. PubMed ID: 12368226
[TBL] [Abstract][Full Text] [Related]
56. Expression of cellular FLICE inhibitory protein, caspase-8, and protease inhibitor-9 in Ewing sarcoma and implications for susceptibility to cytotoxic pathways.
de Hooge AS; Berghuis D; Santos SJ; Mooiman E; Romeo S; Kummer JA; Egeler RM; van Tol MJ; Melief CJ; Hogendoorn PC; Lankester AC
Clin Cancer Res; 2007 Jan; 13(1):206-14. PubMed ID: 17200356
[TBL] [Abstract][Full Text] [Related]
57. Production and characterization of monoclonal antibodies against recombinant extracellular domain of CD99.
Thangaretnam KP; Paramasivam OR; Ramanathan P; Gopisetty G; Rajkumar T
Hum Antibodies; 2019; 27(1):69-83. PubMed ID: 30282350
[TBL] [Abstract][Full Text] [Related]
58. Role of the adhesion molecule CD99 in platelet-neutrophil interactions.
Pliyev BK; Shepelev AV; Ivanova AV
Eur J Haematol; 2013 Nov; 91(5):456-61. PubMed ID: 23889123
[TBL] [Abstract][Full Text] [Related]
59. CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity.
Scotlandi K; Zuntini M; Manara MC; Sciandra M; Rocchi A; Benini S; Nicoletti G; Bernard G; Nanni P; Lollini PL; Bernard A; Picci P
Oncogene; 2007 Oct; 26(46):6604-18. PubMed ID: 17471235
[TBL] [Abstract][Full Text] [Related]
60. The association between CD99 and LMP-1 expression in nasopharyngeal carcinoma.
Kim HS; Kim JS; Kim JS; Park JT; Lee MC; Juhng SW; Cho JH; Park CS
Exp Oncol; 2006 Mar; 28(1):40-3. PubMed ID: 16614706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
